Upper gibleeding. Gastrointestinal haemorrhage, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients with upper gastrointestinal bleeding and treated by epinephrine injection who wanted to participate in the study and do not had allergy to the Inclusion criteria: underwent urgent endoscopy within 24 h after presentation, had peptic ulcers in the distal oesophagus, stomach or duodenum, had high-risk stigmata including active bleeding , nonbleeding visible vessels , or adherent clots , and successful haemostasis was achieved with endoscopic injection of epinephrine. Written informed consent was obtained before enrolment. Exclusion criteria: pregnant; did not obtain initial haemostasis with endoscopic injection of epinephrine; did not give written informed consent; had bleeding tendency (platelet count 3 s of normal, CT and BT prolong or were taking anticoagulants); had uraemia ; bleeding gastric cancer.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No reebleeding. Timepoint: 72h. Method of measurement: patient Symptoms and endoscopy in second 24 h. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital stay and mortality and blood transfusion. Timepoint: 72h. Method of measurement: symptoms. | — |
Countries
Iran (Islamic Republic of)
Contacts
personal